Clinical skills - Bone pain Flashcards
Osteoporosis
A systemic skeletal disease characterised by low bone mass and deterioration of bone tissue, w/ consequent increase in bone fragility and susceptibility to fracture
Commons sites of fractures due to OP
Spine
NOF
Wrist
Consequences of hip fractures
20% of pts die within a year
50% of survivors are incapacitated
20% require long-term residential care
High risk of future fracture or mortality
Types of vertebral fractures
Wedge
Bioconcave
Crush
Non-modifiable risk factors of OP
Age (major determinant of hip fracture risk)
Gender
Previos fragility fracture at a characteristic site
Endocrine e.g. early menopause
Parental hx of hip fracture
Modifibale risk factors for OP
Low BMI
Lifestyle: smoking, alcohol intake
Low bone density
Drugs increasing the risk of OP
Glucocorticoids Epileptics Aromatose inhibitors Dept injections Thiazides
Co-existing comorbdiities increasing risk of OP
DM RhA SLE Epilepsy HIV 1' hyperparathyoidim
Key determinants of peak bone mass and bone loss
Genes Skeletal geometry Body weight Sex hormones Diet Exercise Racial factors
FRAX
Method used to calculate risk of fracture
Similar to Qfracture
Radiological measure of bone
Dual-energy X-ray absorptiometry (DEXA)
Low dose of radiation
T score
The diff between mean bone density between the pt and a healthy young woman
Normal T score
T > 1.0
Low fracture risk
Osteopenic T score
T < 1.0 to -2.5
Above avg fracture risk
OP T score
T < -2.5
High fracture risk
What creates a very high fracture risk
Severe osteoporosis: T < -2.5 plus one or more fractures
Z scores
The diff between mean bone density between the pt and a healthy aged-matched woman
Pathophysiology of OP
BMU
Coupling of osteoclastic and osteoblastic activity
Imbalance of this relationship
Investigations for OP
FBC ESR/CRP Serum calcium (albumin) Alkaline phosphatase Liver tests Thyroid Myeloma screen 25-hydroxyvitamin D (25OHD) PTH Endocrine: sex hormones/ diabetes/ cortisol GI: coeliac disease antibodies Markers of bone marrow Urine Ca excretion
Strategies for treatment of OP and prevention of fractures
Diet Exercise Lifestyle Treat underlying diseases Drug treatment Falls intervention (medical, OT, physio)
Types of drug treatment for OP
Anti-resorptive
Anabolic
Both
Anti-resorptive drug treatment for OP
Bisphosphonates (alendronate, ibandronate, risedronate, zoledronic acid) HRT Calcium and Vitamin D Calcitriol Raloxifene Denosumab
Anabolic drug treatment for OP
Intermittent PTH – Teriparatide (injected daily)
Anti-resorptive anabolic drug treatment for OP
Strontium ranelate – withdrawn
Duration of drug treatment for OP
Uncertain, 3-5 for bisphosphonate or up to 10 yrs. w/ denosumab
Drug holidays?
Consider se of treatment
Steroids –> early bone los
Some s/e of OP drug treatment
ONJ (osteonecrosis of jaw)
Atypical no
AF
GI
Issues w/ diagnosing and treating osteoporosis
Men
Finding patients w/ fractures – fracture liaison service
Glucocorticoid-induced bone loss – bisphosphonates, little long-term data
Diagnosing OP in men
BMD data only rather than fracture reduction
DEXA based on female reference ranges
Look for secondary causes
Osteogenesis Imperfecta
Syndrome of bone fragility due to mutations in type 1 collagen gene Most cases (85-90%) are caused by a dominant genetic defect There are 7 types – type 1 is most common and mildest and type 11 most severe
Variable in OI
Freq of fractures Stature Coloured sclera Laxity of joints and muscles Bone deformity Scoliosis Brittle teeth Deafness - otosclerosis Respiratory failure Collagen abnormalities
What is treatment of OI directed towards
Preventing or controlling symptoms
Maximising independent mobility
Developing optimal bone mass and muscle strength
Recommendations for OI incl
Care of fractures
Extensive surgical and dental procedures
Physical therapy
Can also use wheelchairs and other mobility aids
Osteomalacia
‘Soft bones’
State of the skeleton arising from impairment of mineralisation
Majority arise from disturbance of Vitamin D and phosphate metabolism
Osteoid
Bone protein matrix, made-up of mostly type 1 collagen and needs to mineralise.
Forms of vit D
D2/ ergocalciferol which is plant derived and consumed in food
D3/ cholecalciferol which is formed from the effect of UV-B sunlight on 7-dehydrocholesterol in skin
Metabolism of vit D
Hydoxylated to 25OHD in liver
Hydoxylated to 1,25(OH)2D in liver or can be metabolised in other cells to form 24,25(OH)2D
Actions of calcitriol
Facilitates calcium and phosphate absorption from the gut
Triggers osteoblast RANKL –> activates osteoclasts –> releasing calcium into the circulation
Triggers osteoblast production of a number of mediators resulting in laying down bone osteoid
Decreases PTH synthesis and secretion
Where does Ca absorption occur
Duodenal
Where does Phosphate absorption occur
Entire small intestine
Associations between vit D deficiency and osteomalacia
Dark skinned immigrants and their breastfed babies
Elderly and infirm
Partial gastrectomy/ intestinal malabsorption
Chronic liver disease/ chronic renal failure
Anticonvulsant medication
Strict diets e.g. lacto vegetarian
Excessive high factor sunblock
Rare hereditary cases
Clinical features of rickets
Growth plate formation is abnormal and becomes wide and irregular
Clinical features of osteomalacia
Can exist without symptoms
Bone and muscle pains, however, are common, often non-spp, chronic and widespread
Myalgias and weakness in hip and proximal leg musculature is typical
Bowing of bone
Ddx for osteomalacia
FM
Chronic fatigue
Depression
Radiology for osteomalacia
Bone softening/ deformity: hourglass thorax, bowing of long bones
Increased fractures, biconcave vertebral bodies
Psuedofractures
Psuedofractures
Lucent band of decreased cortical density Perpendicular to bone surface Often multiple \+/- symmetrical \+/- callus formation
Where are psuedofractres typically found
Femoral neck
Pelvis
Ribs
Investigations for osteomalacia
Bone biochem
25OHD is usually <30 nmol/L (12mg/L) and PTH increased >6.9 pmol/L
Renal function needs testing because low GFR is associated w. phosphate retention
Rarely need bone biopsy
Bone biochem for osteomalacia
ACa is usually low
Phosphate may be normal or low
ALP may be normal or increased
Urinary calcium excretion is usually low
Investigations to exclude other condns mimicking osteomalacia
Liver function Folate Iron studies Coeliac Autoantibodies Autoimmune serology
Treatment for osteomalacia
Treat underlying condn
Vitamin D supplements
Ensure adequate dietary Ca